.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Stakeholders

Academia
Employers
Health System
Payers
Providers

Topics

Clinical
Health Care Cost
Health Care Delivery
Insurance
Policy
Technology
Value-Based Care

Institute for Value-Based Medicine

All Coverage
Event Coverage
Interviews
News

About AJMC

AJMC Journals
Anniversary
Author Forms
Authors
Nominate a Rising Leader

About Us
Contact
Editorial Staff
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy

Spinal Muscular Atrophy

EP. 1: Dr John Brandsema Highlights Progress in SMA Treatment and Improved Outcomes for Patients

July 26th 2022

The introduction of 3 FDA-approved therapies for spinal muscular atrophy is enabling clinicians to treat the disease completely different from how it was handled in the past.